903 related articles for article (PubMed ID: 26747862)
1. Pharmacological targeting of CSF1R inhibits microglial proliferation and prevents the progression of Alzheimer's-like pathology.
Olmos-Alonso A; Schetters ST; Sri S; Askew K; Mancuso R; Vargas-Caballero M; Holscher C; Perry VH; Gomez-Nicola D
Brain; 2016 Mar; 139(Pt 3):891-907. PubMed ID: 26747862
[TBL] [Abstract][Full Text] [Related]
2. Colony-stimulating factor 1 receptor inhibition prevents microglial plaque association and improves cognition in 3xTg-AD mice.
Dagher NN; Najafi AR; Kayala KM; Elmore MR; White TE; Medeiros R; West BL; Green KN
J Neuroinflammation; 2015 Aug; 12():139. PubMed ID: 26232154
[TBL] [Abstract][Full Text] [Related]
3. Eliminating microglia in Alzheimer's mice prevents neuronal loss without modulating amyloid-β pathology.
Spangenberg EE; Lee RJ; Najafi AR; Rice RA; Elmore MR; Blurton-Jones M; West BL; Green KN
Brain; 2016 Apr; 139(Pt 4):1265-81. PubMed ID: 26921617
[TBL] [Abstract][Full Text] [Related]
4. Microglia depletion rapidly and reversibly alters amyloid pathology by modification of plaque compaction and morphologies.
Casali BT; MacPherson KP; Reed-Geaghan EG; Landreth GE
Neurobiol Dis; 2020 Aug; 142():104956. PubMed ID: 32479996
[TBL] [Abstract][Full Text] [Related]
5. CSF1R inhibitor JNJ-40346527 attenuates microglial proliferation and neurodegeneration in P301S mice.
Mancuso R; Fryatt G; Cleal M; Obst J; Pipi E; Monzón-Sandoval J; Ribe E; Winchester L; Webber C; Nevado A; Jacobs T; Austin N; Theunis C; Grauwen K; Daniela Ruiz E; Mudher A; Vicente-Rodriguez M; Parker CA; Simmons C; Cash D; Richardson J; ; Jones DNC; Lovestone S; Gómez-Nicola D; Perry VH
Brain; 2019 Oct; 142(10):3243-3264. PubMed ID: 31504240
[TBL] [Abstract][Full Text] [Related]
6. Pharmacological inhibition of CSF1R by GW2580 reduces microglial proliferation and is protective against neuroinflammation and dopaminergic neurodegeneration.
Neal ML; Fleming SM; Budge KM; Boyle AM; Kim C; Alam G; Beier EE; Wu LJ; Richardson JR
FASEB J; 2020 Jan; 34(1):1679-1694. PubMed ID: 31914683
[TBL] [Abstract][Full Text] [Related]
7. Early long-term administration of the CSF1R inhibitor PLX3397 ablates microglia and reduces accumulation of intraneuronal amyloid, neuritic plaque deposition and pre-fibrillar oligomers in 5XFAD mouse model of Alzheimer's disease.
Sosna J; Philipp S; Albay R; Reyes-Ruiz JM; Baglietto-Vargas D; LaFerla FM; Glabe CG
Mol Neurodegener; 2018 Mar; 13(1):11. PubMed ID: 29490706
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of IL-34 Unveils Tissue-Selectivity and Is Sufficient to Reduce Microglial Proliferation in a Model of Chronic Neurodegeneration.
Obst J; Simon E; Martin-Estebane M; Pipi E; Barkwill LM; Gonzalez-Rivera I; Buchanan F; Prescott AR; Faust D; Fox S; Brownlees J; Taylor D; Perry VH; Nuthall H; Atkinson PJ; Karran E; Routledge C; Gomez-Nicola D
Front Immunol; 2020; 11():579000. PubMed ID: 33162994
[TBL] [Abstract][Full Text] [Related]
9. Sustained microglial depletion with CSF1R inhibitor impairs parenchymal plaque development in an Alzheimer's disease model.
Spangenberg E; Severson PL; Hohsfield LA; Crapser J; Zhang J; Burton EA; Zhang Y; Spevak W; Lin J; Phan NY; Habets G; Rymar A; Tsang G; Walters J; Nespi M; Singh P; Broome S; Ibrahim P; Zhang C; Bollag G; West BL; Green KN
Nat Commun; 2019 Aug; 10(1):3758. PubMed ID: 31434879
[TBL] [Abstract][Full Text] [Related]
10. CSF1R blockade slows the progression of amyotrophic lateral sclerosis by reducing microgliosis and invasion of macrophages into peripheral nerves.
Martínez-Muriana A; Mancuso R; Francos-Quijorna I; Olmos-Alonso A; Osta R; Perry VH; Navarro X; Gomez-Nicola D; López-Vales R
Sci Rep; 2016 May; 6():25663. PubMed ID: 27174644
[TBL] [Abstract][Full Text] [Related]
11. Microglia prevent peripheral immune cell invasion and promote an anti-inflammatory environment in the brain of APP-PS1 transgenic mice.
Unger MS; Schernthaner P; Marschallinger J; Mrowetz H; Aigner L
J Neuroinflammation; 2018 Sep; 15(1):274. PubMed ID: 30241479
[TBL] [Abstract][Full Text] [Related]
12. CSF1R inhibition rescues tau pathology and neurodegeneration in an A/T/N model with combined AD pathologies, while preserving plaque associated microglia.
Lodder C; Scheyltjens I; Stancu IC; Botella Lucena P; Gutiérrez de Ravé M; Vanherle S; Vanmierlo T; Cremers N; Vanrusselt H; Brône B; Hanseeuw B; Octave JN; Bottelbergs A; Movahedi K; Dewachter I
Acta Neuropathol Commun; 2021 Jun; 9(1):108. PubMed ID: 34103079
[TBL] [Abstract][Full Text] [Related]
13. The effect of focal brain injury on beta-amyloid plaque deposition, inflammation and synapses in the APP/PS1 mouse model of Alzheimer's disease.
Collins JM; King AE; Woodhouse A; Kirkcaldie MT; Vickers JC
Exp Neurol; 2015 May; 267():219-29. PubMed ID: 25747037
[TBL] [Abstract][Full Text] [Related]
14. Knock-in models related to Alzheimer's disease: synaptic transmission, plaques and the role of microglia.
Benitez DP; Jiang S; Wood J; Wang R; Hall CM; Peerboom C; Wong N; Stringer KM; Vitanova KS; Smith VC; Joshi D; Saito T; Saido TC; Hardy J; Hanrieder J; De Strooper B; Salih DA; Tripathi T; Edwards FA; Cummings DM
Mol Neurodegener; 2021 Jul; 16(1):47. PubMed ID: 34266459
[TBL] [Abstract][Full Text] [Related]
15. The incretin analogue D-Ala2GIP reduces plaque load, astrogliosis and oxidative stress in an APP/PS1 mouse model of Alzheimer's disease.
Duffy AM; Hölscher C
Neuroscience; 2013 Jan; 228():294-300. PubMed ID: 23103794
[TBL] [Abstract][Full Text] [Related]
16. Differential Regulation of Microglial Activation in Response to Different Degree of Ischemia.
Gao H; Ju F; Ti R; Zhang Y; Zhang S
Front Immunol; 2022; 13():792638. PubMed ID: 35154109
[TBL] [Abstract][Full Text] [Related]
17. Conditional genetic deletion of CSF1 receptor in microglia ameliorates the physiopathology of Alzheimer's disease.
Pons V; Lévesque P; Plante MM; Rivest S
Alzheimers Res Ther; 2021 Jan; 13(1):8. PubMed ID: 33402196
[TBL] [Abstract][Full Text] [Related]
18. Inhibiting microglia proliferation after spinal cord injury improves recovery in mice and nonhuman primates.
Poulen G; Aloy E; Bringuier CM; Mestre-Francés N; Artus EVF; Cardoso M; Perez JC; Goze-Bac C; Boukhaddaoui H; Lonjon N; Gerber YN; Perrin FE
Theranostics; 2021; 11(18):8640-8659. PubMed ID: 34522204
[TBL] [Abstract][Full Text] [Related]
19. Selective targeting and modulation of plaque associated microglia via systemic hydroxyl dendrimer administration in an Alzheimer's disease mouse model.
Henningfield CM; Soni N; Lee RW; Sharma R; Cleland JL; Green KN
Alzheimers Res Ther; 2024 May; 16(1):101. PubMed ID: 38711159
[TBL] [Abstract][Full Text] [Related]
20. PET imaging of microglia by targeting macrophage colony-stimulating factor 1 receptor (CSF1R).
Horti AG; Naik R; Foss CA; Minn I; Misheneva V; Du Y; Wang Y; Mathews WB; Wu Y; Hall A; LaCourse C; Ahn HH; Nam H; Lesniak WG; Valentine H; Pletnikova O; Troncoso JC; Smith MD; Calabresi PA; Savonenko AV; Dannals RF; Pletnikov MV; Pomper MG
Proc Natl Acad Sci U S A; 2019 Jan; 116(5):1686-1691. PubMed ID: 30635412
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
